ATE362756T1 - Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen - Google Patents

Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen

Info

Publication number
ATE362756T1
ATE362756T1 AT03758040T AT03758040T ATE362756T1 AT E362756 T1 ATE362756 T1 AT E362756T1 AT 03758040 T AT03758040 T AT 03758040T AT 03758040 T AT03758040 T AT 03758040T AT E362756 T1 ATE362756 T1 AT E362756T1
Authority
AT
Austria
Prior art keywords
pain
acid salts
free injection
injection preparations
arylpropionic acid
Prior art date
Application number
AT03758040T
Other languages
English (en)
Inventor
Marco Gentile
Maria Dragani
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Application granted granted Critical
Publication of ATE362756T1 publication Critical patent/ATE362756T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03758040T 2002-10-25 2003-10-22 Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen ATE362756T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02023954 2002-10-25

Publications (1)

Publication Number Publication Date
ATE362756T1 true ATE362756T1 (de) 2007-06-15

Family

ID=32116228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758040T ATE362756T1 (de) 2002-10-25 2003-10-22 Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen

Country Status (10)

Country Link
US (1) US7442832B2 (de)
EP (1) EP1558234B1 (de)
CN (1) CN1329029C (de)
AT (1) ATE362756T1 (de)
AU (1) AU2003274060A1 (de)
DE (1) DE60313998T2 (de)
ES (1) ES2287519T3 (de)
MX (1) MXPA05004377A (de)
RU (1) RU2340334C2 (de)
WO (1) WO2004037242A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2526996B1 (de) 2002-12-20 2019-09-11 Xeris Pharmaceuticals, Inc. Formulierung für intrakutane Injektion
BRPI0707698A2 (pt) * 2006-02-06 2011-05-10 Pharmaceutical Solutions Inc preparaÇÕes nço esteroidais antiinflamatàrias orais lÍquidas e em pà para administraÇço a animais
FR2950533B1 (fr) * 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
ES2621304T3 (es) 2011-03-10 2017-07-03 Xeris Pharmaceuticals, Inc. Formulaciones estables para inyección parenteral de fármacos peptídicos
DK2773331T3 (en) 2011-10-31 2016-03-14 Xeris Pharmaceuticals Inc Formulations for the treatment of diabetes
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN102885766B (zh) * 2012-11-05 2014-06-18 西安德天药业股份有限公司 一种右旋酮洛芬注射液及其制备方法
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
JP6982495B2 (ja) 2014-08-06 2021-12-17 ゼリス ファーマシューティカルズ インコーポレイテッド ペーストの皮内および／または皮下注射のためのシリンジ、キット、および方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
JP7299166B2 (ja) 2017-06-02 2023-06-27 ゼリス ファーマシューティカルズ インコーポレイテッド 沈殿抵抗性低分子薬物製剤
EP3670489A1 (de) 2018-12-21 2020-06-24 Dompé farmaceutici S.p.A. Cokristall von ketoprofen, zusammensetzungen damit, verfahren zur herstellung davon und verwendungen davon
DK3996699T3 (da) 2019-07-09 2023-07-24 Farmalider Sa Kombination af ibuprofen og tramadol til smertelindring
EP3842408A1 (de) 2019-12-23 2021-06-30 Dompé farmaceutici S.p.A. Co-kristall von ketoprofen und dessen herstellung, pharmazeutische zusammensetzungen damit und verwendungen davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3949720B2 (ja) * 1995-09-07 2007-07-25 ロレアル 非光合成糸状細菌からの抽出物の使用とそれを含む組成物
IT1277741B1 (it) * 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
CN1260172A (zh) * 1998-12-18 2000-07-19 国家医药管理局上海医药工业研究院 右旋酮洛芬制剂
US6342530B1 (en) * 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt

Also Published As

Publication number Publication date
EP1558234A1 (de) 2005-08-03
RU2005115865A (ru) 2006-01-20
EP1558234B1 (de) 2007-05-23
AU2003274060A1 (en) 2004-05-13
ES2287519T3 (es) 2007-12-16
WO2004037242A1 (en) 2004-05-06
US7442832B2 (en) 2008-10-28
RU2340334C2 (ru) 2008-12-10
HK1084336A1 (en) 2006-07-28
CN1720037A (zh) 2006-01-11
CN1329029C (zh) 2007-08-01
MXPA05004377A (es) 2005-07-26
DE60313998T2 (de) 2008-01-31
US20060058386A1 (en) 2006-03-16
DE60313998D1 (de) 2007-07-05

Similar Documents

Publication Publication Date Title
ATE362756T1 (de) Schmerzfreie injektions-zubereitungen von 2- arylpropionsäuresalzen
EA199700201A1 (ru) Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот
EA200701913A1 (ru) Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом
HUP9803044A2 (hu) Ibuprofentartalmú készítmény
ES2099022B1 (es) Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
TR200200252T2 (tr) Şimerik polipeptidler, bunların üretimi için yöntem ve kullanımı
NZ592510A (en) HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same
EA200000331A1 (ru) Фармацевтические композиции, содержащие белок плазмы
ATE195417T1 (de) Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
DE69622157D1 (de) Zusammensetzung zur verhinderung von osteolyse und metastasen
RU95112575A (ru) Соль арилпропионовой кислоты, способ ее получения и фармацевтическая композиция
EA200100168A1 (ru) Схема лечения при введении фенилацетилглутамина, фенилацетилизоглутамина и/или фенилацетата
PL321238A1 (en) Compositions of amino acids and their application in clinical nourishing
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
DK0977560T3 (da) Ibuprofen-thioestere som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer (CoA-thioestere af arylpropionsyrer, aryleddikesyrer og salicylater som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer)
ATE401350T1 (de) Dentalzubereitungen enthaltend peptide, die das knochenwachstum fördern
DE60110185D1 (de) Zusammensetzung und Verfahren zur parenteralen Anwendung von Ibuprofen-D,L-, oder L-Lysinat
EP1285660A4 (de) Zinksupplement-zusammensetzungen zur oralen verabreichung
FR2741076B1 (fr) Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
WO2002058589A3 (en) Agents and methods for promoting bone growth
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
JPS6048925A (ja) 安定なｓ−アデノシル−ｌ−メチオニン塩を含有する注射可能な治療用組成物
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
DE50010973D1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties